Niccolò Buetti Selected Research

Catheter-Related Infections

1/2022	Development and validation of a multivariable prediction model of central venous catheter-tip colonization in a cohort of five randomized trials.
10/2021	Practices and intravascular catheter infection during on- and off-hours in critically ill patients.
9/2021	Concurrent systemic antibiotics at catheter insertion and intravascular catheter-related infection in the ICU: a post hoc analysis using individual data from five large RCTs.
4/2021	Obesity and risk of catheter-related infections in the ICU. A post hoc analysis of four large randomized controlled trials.
1/2021	Ultrasound Guidance and Risk for Central Venous Catheter-Related Infections in the Intensive Care Unit: A Post Hoc Analysis of Individual Data of 3 Multicenter Randomized Trials.
1/2021	Treatment duration of enterococcal intravascular catheter-related infections.
7/2020	Ultrasound guidance and risk for intravascular catheter-related infections among peripheral arterial catheters: a post-hoc analysis of two large randomized-controlled trials.
1/2020	The Insertion Site Should Be Considered for the Empirical Therapy of Short-Term Central Venous and Arterial Catheter-Related Infections.
12/2019	Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niccolò Buetti Research Topics

Disease

21	Sepsis (Septicemia) 01/2022 - 10/2018
16	Infections 01/2022 - 01/2019
9	Catheter-Related Infections 01/2022 - 12/2019
8	Critical Illness (Critically Ill) 10/2021 - 01/2020
6	COVID-19 01/2022 - 01/2020
1	Septic Shock (Toxic Shock Syndrome) 03/2022
1	Hypophosphatemia 01/2022
1	Obesity 01/2022
1	Candidemia 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Inflammation (Inflammations) 12/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Thrombophlebitis 01/2019
1	Fever (Fevers) 01/2019
1	Shock 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Endocarditis 01/2019
1	Bacteremia 01/2019
1	Coinfection 01/2016

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2019
4	CoagulaseIBA 09/2021 - 01/2016
2	Polyvinyl Chloride (PVC)IBA 01/2022 - 11/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	Viral RNAIBA 12/2020
1	Vancomycin FDA LinkGeneric 12/2020
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2020

Therapy/Procedure

22	Catheters 01/2022 - 10/2018
6	Central Venous Catheters 01/2022 - 01/2019
3	Therapeutics 09/2021 - 01/2019
2	Length of Stay 01/2022 - 12/2021
2	Personal Protective Equipment 06/2021 - 10/2020
2	Critical Care (Surgical Intensive Care) 06/2021 - 10/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Resuscitation 12/2021
1	Duration of Therapy 01/2021